bromodeoxyuridine has been researched along with Parkinson Disease, Secondary in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Fu, W; Li, F; Lv, C; Wang, X; Zhuang, W | 1 |
| Chen, Y; Ding, Z; Jiang, Y; Ren, H; Su, Y; Wang, J; Wu, J; Yu, W | 1 |
| Agari, T; Baba, T; Date, I; Fujino, H; Furuta, T; Jing, M; Kadota, T; Kikuchi, Y; Kondo, A; Kuramoto, S; Miyoshi, Y; Morimoto, T; Obata, F; Shingo, T; Tajiri, N; Takeda, I; Tayra, JT; Wang, F; Yasuhara, T; Yuan, W | 1 |
| Bez, A; Pagano, SF; Parati, EA; Ponti, D; Pozzi, S; Sala, S | 1 |
| Broaddus, WC; Fillmore, HL; Holloway, KL; Richardson, RM | 1 |
| Jiao, Y; Shepherd, KR; Smeyne, M; Smeyne, RJ | 1 |
| Besnard, JC; Bodard, S; Bouchez, G; Chalon, S; Charbord, P; Garreau, L; Guilloteau, D; Rico, A; Sensebé, L; Vourc'h, P | 1 |
| Collier, TJ; Sladek, JR; Sortwell, CE | 1 |
8 other study(ies) available for bromodeoxyuridine and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson's disease.
Topics: Animals; Antigens, CD; Bromodeoxyuridine; Cell Differentiation; Cell Movement; Disease Models, Animal; Glial Fibrillary Acidic Protein; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Microtubule-Associated Proteins; Nerve Fibers; Nestin; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Substantia Nigra; Sympatholytics; Treatment Outcome; Tyrosine 3-Monooxygenase | 2017 |
Intrastriatal transplantation of GDNF-engineered BMSCs and its neuroprotection in lactacystin-induced Parkinsonian rat model.
Topics: Acetylcysteine; Animals; Antimetabolites; Apomorphine; Behavior, Animal; Blotting, Western; Bone Marrow Transplantation; Bromodeoxyuridine; Cysteine Proteinase Inhibitors; Dopamine; Dopamine Agonists; Glial Cell Line-Derived Neurotrophic Factor; Immunohistochemistry; Neostriatum; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Tissue Engineering; Tyrosine 3-Monooxygenase | 2010 |
Exercise exerts neuroprotective effects on Parkinson's disease model of rats.
Topics: Amphetamine; Animals; Ascorbic Acid; Behavior, Animal; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Cell Proliferation; Corpus Striatum; Disease Models, Animal; Doublecortin Domain Proteins; Doublecortin Protein; Exercise Test; Female; Glial Cell Line-Derived Neurotrophic Factors; Microtubule-Associated Proteins; Movement; Neuropeptides; Oxidopamine; Parkinson Disease, Secondary; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Rotation; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase | 2010 |
Neural stem cells. Biological features and therapeutic potential in Parkinson's disease.
Topics: Animals; Bromodeoxyuridine; Cell Differentiation; Immunohistochemistry; Mice; Mice, Inbred Strains; Neurons; Olfactory Bulb; Oxidopamine; Parkinson Disease, Secondary; Phenotype; Recovery of Function; Stem Cell Transplantation; Stem Cells; Tyrosine 3-Monooxygenase | 2003 |
Grafts of adult subependymal zone neuronal progenitor cells rescue hemiparkinsonian behavioral decline.
Topics: Animals; Behavior, Animal; Bromodeoxyuridine; Cell Count; Cell Differentiation; Cell Movement; Cells, Cultured; Corpus Striatum; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Ependyma; Female; Glial Fibrillary Acidic Protein; Green Fluorescent Proteins; Indoles; Intermediate Filament Proteins; Male; Membrane Glycoproteins; Membrane Transport Proteins; Motor Activity; Nerve Tissue Proteins; Nestin; Neurons; Oxidopamine; Parkinson Disease, Secondary; Phenotype; Phosphopyruvate Hydratase; Rats; Rats, Inbred F344; Rotarod Performance Test; Stem Cell Transplantation; Stem Cells; Time Factors; Tubulin; Tyrosine 3-Monooxygenase | 2005 |
Glia cell number modulates sensitivity to MPTP in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antimetabolites; Bromodeoxyuridine; Cell Count; Cells, Cultured; Dopamine Agents; Drug Resistance; Glial Fibrillary Acidic Protein; Immunohistochemistry; Mice; Mice, Inbred C57BL; Neuroglia; Parkinson Disease, Secondary; S100 Proteins; Substantia Nigra | 2005 |
Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease.
Topics: Animals; Antimetabolites; Behavior, Animal; Bromodeoxyuridine; Cells, Cultured; DNA Primers; Dopamine; Dopamine Plasma Membrane Transport Proteins; Immunohistochemistry; Male; Mesenchymal Stem Cell Transplantation; Microdialysis; Neostriatum; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Reverse Transcriptase Polymerase Chain Reaction; RNA; Signal Transduction; Substantia Nigra; Tyrosine 3-Monooxygenase; Vesicular Monoamine Transport Proteins | 2008 |
Co-grafted embryonic striatum increases the survival of grafted embryonic dopamine neurons.
Topics: Animals; Antimetabolites; Behavior, Animal; Brain Tissue Transplantation; Bromodeoxyuridine; Corpus Striatum; Dopamine; Fetal Tissue Transplantation; Graft Survival; Male; Nerve Regeneration; Neurons; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Inbred F344; Rotation; Substantia Nigra; Sympatholytics; Tyrosine 3-Monooxygenase | 1998 |